Chengda Pharmaceutical, less than 10 days of broken waist and then waist cut, the nightmare of many retail investors
Chengda Pharmaceutical, the authentic Pfizer new crown special effects raw material supplier, is unanimously optimistic about a large number of retail investors, it is expected to be shorted by the margin, from 188 all the way down to most of the half, the current price is only about 67, less than 10 days on the listing broke!
It should be said that the concept of Chengda is hard enough, the performance is not bad, on the first day of listing, it doubled in one fell swoop, the highest price was 188, but then it fell all the way down, and it was directly broken, not even a fraction! Who is crazy about Cinda?
Look at the small scatter of ghosts crying wolf howling in the jar, many costs are more than 100, which is estimated to be difficult to untie, unless you do T back and forth to reduce costs!
From the technical analysis point of view, today's big fall, fell below the small platform, there are signs of a break, if tomorrow continues to fall, the probability of the second bottom, 40 estimates can not hold! It's rare for a new stock to move so wildly!
Of course, the general situation is very unfavorable to such pharmaceutical stocks, WuXi AppTec has been affected by US policies and has plummeted, and Chengda's R&D outsourcing has also been deeply affected! If WuXi AppTec can rebound and breathe tomorrow, there is a high probability that Chengda will rebound! Maybe it can change the trend!
Tomorrow is a key day for Chengda, if it continues to fall, it will not be bottomless, and the rebound is expected to hold the platform to open a round of rebound! Wait and see, the most authentic Pfizer COVID-19 drug partner!
